1. Home
  2. MRSN vs ANGH Comparison

MRSN vs ANGH Comparison

Compare MRSN & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • ANGH
  • Stock Information
  • Founded
  • MRSN 2001
  • ANGH 2012
  • Country
  • MRSN United States
  • ANGH United Arab Emirates
  • Employees
  • MRSN N/A
  • ANGH N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • ANGH Telecommunications Equipment
  • Sector
  • MRSN Health Care
  • ANGH Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • ANGH Nasdaq
  • Market Cap
  • MRSN 37.0M
  • ANGH 32.1M
  • IPO Year
  • MRSN 2017
  • ANGH N/A
  • Fundamental
  • Price
  • MRSN $7.15
  • ANGH $3.24
  • Analyst Decision
  • MRSN Strong Buy
  • ANGH
  • Analyst Count
  • MRSN 3
  • ANGH 0
  • Target Price
  • MRSN $33.00
  • ANGH N/A
  • AVG Volume (30 Days)
  • MRSN 62.6K
  • ANGH 13.2K
  • Earning Date
  • MRSN 11-12-2025
  • ANGH 09-30-2025
  • Dividend Yield
  • MRSN N/A
  • ANGH N/A
  • EPS Growth
  • MRSN N/A
  • ANGH N/A
  • EPS
  • MRSN N/A
  • ANGH N/A
  • Revenue
  • MRSN $34,769,000.00
  • ANGH $78,093,405.00
  • Revenue This Year
  • MRSN N/A
  • ANGH N/A
  • Revenue Next Year
  • MRSN N/A
  • ANGH N/A
  • P/E Ratio
  • MRSN N/A
  • ANGH N/A
  • Revenue Growth
  • MRSN 16.14
  • ANGH 88.72
  • 52 Week Low
  • MRSN $5.21
  • ANGH $2.53
  • 52 Week High
  • MRSN $70.75
  • ANGH $9.40
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 47.47
  • ANGH 45.07
  • Support Level
  • MRSN $7.04
  • ANGH $3.14
  • Resistance Level
  • MRSN $7.49
  • ANGH $3.35
  • Average True Range (ATR)
  • MRSN 0.44
  • ANGH 0.27
  • MACD
  • MRSN 0.00
  • ANGH 0.05
  • Stochastic Oscillator
  • MRSN 36.53
  • ANGH 59.15

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

Share on Social Networks: